E
Edwin D. Charlebois
Researcher at University of California, San Francisco
Publications - 236
Citations - 13880
Edwin D. Charlebois is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Population & Acquired immunodeficiency syndrome (AIDS). The author has an hindex of 60, co-authored 216 publications receiving 12742 citations. Previous affiliations of Edwin D. Charlebois include University of California, Berkeley & University of Pennsylvania.
Papers
More filters
Journal ArticleDOI
Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population.
David R. Bangsberg,Frederick Hecht,Edwin D. Charlebois,Andrew R. Zolopa,Mark Holodniy,Mark Holodniy,Lewis B. Sheiner,Joshua D. Bamberger,Margaret A. Chesney,Andrew R. Moss +9 more
TL;DR: A substantial proportion of homeless and marginally housed individuals had good adherence to PI therapy and a strong relationship was found between independent methods of measuring adherence and concurrent viral suppression.
Journal ArticleDOI
Non-adherence to highly active antiretroviral therapy predicts progression to Aids
David R. Bangsberg,Sharon Perry,Edwin D. Charlebois,Richard A.F. Clark,Marjorie Roberston,Andrew R. Zolopa,Andrew R. Moss +6 more
TL;DR: The introduction of highly active antiretroviral therapy (HAART) has produced a dramatic reduction in mortality among HIV-infected individuals, and the level of adherence to HAART is closely associated with suppression of the HIV viral load in plasma.
Journal ArticleDOI
High prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections
Bradley W. Frazee,Jeremy Lynn,Edwin D. Charlebois,Larry Lambert,Derrick Lowery,Francoise Perdreau-Remington +5 more
TL;DR: In this urban ED population, MRSA is a major pathogen in skin and soft tissue infections and should be considered when empiric antibiotic therapy is selected for such infections.
Journal ArticleDOI
Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale.
Thomas P. Giordano,David Sanchez-Migallon Guzman,Richard A.F. Clark,Edwin D. Charlebois,David R. Bangsberg +4 more
TL;DR: A visual analogue scale to assess adherence was performed as well as a more complicated 3-day recall instrument in this diverse population of HIV-infected patients, and may be useful in routine patient care.
Journal ArticleDOI
Decline in HIV infectivity following the introduction of highly active antiretroviral therapy.
Travis C. Porco,Jeffrey N. Martin,Kimberly Page-Shafer,Amber Cheng,Edwin D. Charlebois,Robert M. Grant,Dennis Osmond +6 more
TL;DR: Use of HAART by infected persons in a community appears to reduce their infectiousness and therefore may provide an important HIV prevention tool.